Hansa Biopharma AB, "Hansa" , today announced that results from its US Phase 3 ConfIdeS trial in kidney transplantation have been accepted and selected as a late-breaking abstract for an oral ...
Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that results from its US Phase 3 ConfIdeS trial in kidney transplantation have ...
For 13 years, the Gainesville Fire-Rescue “Firefighters As Role Models” Program has been making an impact, helping students ...
SVSTDPC (Swami Vivekanand Scholarship for Technical Diploma in Professional Courses) details including status check, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results